Searching the Resource Information Network

Our searching services are busy right now. Please try again later

  • Register
X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X

Leaving Community

Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.

No
Yes

Targeting PPAR-gamma counteracts tumour adaptation to immune-checkpoint blockade in hepatocellular carcinoma.

Zhewen Xiong | Stephen Lam Chan | Jingying Zhou | Joaquim S L Vong | Tsz Tung Kwong | Xuezhen Zeng | Haoran Wu | Jianquan Cao | Yalin Tu | Yu Feng | Weiqin Yang | Patrick Pak-Chun Wong | Willis Wai-Yiu Si-Tou | Xiaoyu Liu | Jing Wang | Wenshu Tang | Zhixian Liang | Jiahuan Lu | Ka Man Li | Jie-Ting Low | Michael Wing-Yan Chan | Howard H W Leung | Anthony W H Chan | Ka-Fai To | Kevin Yuk-Lap Yip | Yuk Ming Dennis Lo | Joseph Jao-Yiu Sung | Alfred Sze-Lok Cheng
Gut | 2023

Therapy-induced tumour microenvironment (TME) remodelling poses a major hurdle for cancer cure. As the majority of patients with hepatocellular carcinoma (HCC) exhibits primary or acquired resistance to antiprogrammed cell death (ligand)-1 (anti-PD-[L]1) therapies, we aimed to investigate the mechanisms underlying tumour adaptation to immune-checkpoint targeting.

Pubmed ID: 37019619

Research resources used in this publication

None found

Additional research tools detected in this publication

Antibodies used in this publication

None found

Associated grants

None

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


C57BL/6J (tool)

RRID:IMSR_JAX:000664

Mus musculus with name C57BL/6J from IMSR.

View all literature mentions